Abstract
Diseases associated with chronic inflammatory pathology claim a major share of worldwide deaths each year. A principal reasonbehind the huge number of casualties is associated with mild or unnoticed symptoms for long period of time since the outset, and thatspecific treatment options for these diseases have not yet emerged. Current anti-inflammatory drugs essentially have become ineffectivefor long term protection from these diseases as they also interfere with essential cellular pathways and associated toxicities. Notably, recentstudies with a number of phytochemicals have shown promising results. These compounds isolated from various medicinal plantsexpress their anti-inflammatory activities by down regulating expression of several crucial pro-inflammatory mediators. These are mostlyantioxidants; inhibit induction of key transcription factors like nuclear factor kappa B (NF-κB) that are responsible for expression of proinflammatorymediators, and other growth regulators. Definitely, some of these compounds have the potential to be developed into newtherapeutic agents to better control inflammation associated diseases in near future. This review summarizes recent findings on the molecularmechanisms through which various inflammatory activities are linked to disease progression and a group of natural products thathave shown promise in controlling these processes.
Keywords:Inflammation, natural products, nuclear factor kappa B (NF-κB), toll like receptor (TLR), cytokines, interleukin.
Current Pharmaceutical Design
Title:Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine
Volume: 22Issue: 2
Author(s):Nilanjan Ghosh, Asif Ali, Rituparna Ghosh, Shaileyee Das, Subhash C. Mandal and Mahadeb Pal
Affiliation:
Keywords:Inflammation, natural products, nuclear factor kappa B (NF-κB), toll like receptor (TLR), cytokines, interleukin.
Abstract: Diseases associated with chronic inflammatory pathology claim a major share of worldwide deaths each year. A principal reasonbehind the huge number of casualties is associated with mild or unnoticed symptoms for long period of time since the outset, and thatspecific treatment options for these diseases have not yet emerged. Current anti-inflammatory drugs essentially have become ineffectivefor long term protection from these diseases as they also interfere with essential cellular pathways and associated toxicities. Notably, recentstudies with a number of phytochemicals have shown promising results. These compounds isolated from various medicinal plantsexpress their anti-inflammatory activities by down regulating expression of several crucial pro-inflammatory mediators. These are mostlyantioxidants; inhibit induction of key transcription factors like nuclear factor kappa B (NF-κB) that are responsible for expression of proinflammatorymediators, and other growth regulators. Definitely, some of these compounds have the potential to be developed into newtherapeutic agents to better control inflammation associated diseases in near future. This review summarizes recent findings on the molecularmechanisms through which various inflammatory activities are linked to disease progression and a group of natural products thathave shown promise in controlling these processes.
Export Options
About this article
Cite this article as:
Ghosh Nilanjan, Ali Asif, Ghosh Rituparna, Das Shaileyee, Mandal C. Subhash and Pal Mahadeb, Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine, Current Pharmaceutical Design 2016; 22 (2) .https://dx.doi.org/10.2174/1381612822666151112151419
DOI https://dx.doi.org/10.2174/1381612822666151112151419 | Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher | Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employed in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, and prediction, to monitoring of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
- Epigenetic Mechanisms and Kidney Diseases
Current Medicinal ChemistryBody Fat Distribution Contributes to Defining the Relationship betweenInsulin Resistance and Obesity in Human Diseases
Current Diabetes ReviewsCardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?
Current Vascular Pharmacology RNA Metabolism in Neurodegenerative Disease
Current Chemical BiologyCardiovascular Disease Burden and Risk Factors Before and After Kidney Transplant
Cardiovascular & Hematological Disorders-Drug Targets Sleep Related Disorders in the Elderly: An Overview
Current Respiratory Medicine ReviewsCardiovascular Magnetic Resonance for Evaluation of Heart Involvement in ANCA-Associated Vasculitis. A Luxury or a Valuable Diagnostic Tool?
Inflammation & Allergy - Drug Targets (Discontinued)Dual Inhibitors of β-Amyloid Aggregation and Acetylcholinesterase as Multi-Target Anti-Alzheimer Drug Candidates
Current Topics in Medicinal Chemistry Mediterranean Diet and Longevity
Current Nutrition & Food ScienceDevelopment Course and an Application Strategy for Induced Pluripotent Stem Cells in Regenerative Medicine
Current Stem Cell Research & TherapyABC Transporters in Neurological Disorders: An Important Gateway for Botanical Compounds Mediated Neuro-Therapeutics
Current Topics in Medicinal ChemistryBiomarkers for Diagnosing and Staging of Fabry Disease
Current Medicinal ChemistryEpidemiological Characteristics of 64 Covid-19 Patients in Errachidia Province (Darâa-Tafilalet region), Morocco: A Retrospective Analysis
Reviews on Recent Clinical TrialsPCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?
Current Pharmaceutical DesignMultitarget Drugs of Plants Origin Acting on Alzheimer's Disease
Current Medicinal ChemistryInterplay of Immunity and Vitamin D: Interactions and Implications with Current IBD Therapy
Current Medicinal ChemistryBioadhesive Films as Drug Delivery Systems
Drug Delivery LettersAnti-inflammatory Effect of Electro-acupuncture via Reduction in Colonic Peristalsis in a Mouse Model of Inflammatory Bowel Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Role of Orexin System in Antipsychotics Induced Weight Gain
Current Psychiatry Reviews“Non-Classical” Indication for Provocative Testing of Growth Hormone: A Retrospective Cohort Study in Adult Patients Under Replacement Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets
[8]ページ先頭